Monopar Therapeutics Inc.

NASDAQ:MNPR

Biotechnology

Healthcare
$71.06 +2.45%

+$1.58 today

Market cap
$481.56M
Beta
1.54
P/E (TTM)
-37.6
EPS (TTM)
-$1.76
52W Low $29.18High $105.00

Volume 0.12M

Average 0.17M

MNPR Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How MNPR compares with its peers on the latest reported figures

MNPR Competitors Peer median
Net Margin for MNPR and competitors
Company Period LTM level YoY 3-year change
ATNMActinium Pharmaceuticals, Inc.LTM Jun 202632.2% —-34446.7 pp
ZYMEZymeworks Inc.LTM Sep 202616.3% +63.4 pp-106.7 pp
MGNXMacroGenics, Inc.LTM Mar 2026-44.8% -8.2 pp+29.9 pp
XNCRXencor, Inc.LTM Jun 2026-155.6% -46.5 pp-39.7 pp
ADCTADC Therapeutics S.A.LTM Mar 2026-173.0% +24.6 pp-100.4 pp
BCYCBicycle Therapeutics plcLTM Mar 2026-345.0% +445.1 pp+477.7 pp
IPHAInnate Pharma S.A.FY2025-1764.5% -1372.5 pp-1663.8 pp
IMNMImmunome, Inc.FY2025-3060.0% +180.4 pp—
MNPRMonopar Therapeutics Inc.FY2025— ——
ALXOALX Oncology Holdings Inc.FY2025— ——
CMPXCompass Therapeutics, Inc.FY2025— ——
Peer median (excluding MNPR) -164.3%+24.6 pp-100.4 pp

Competitors are the stored peer set for MNPR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development6.49M7.59M5.6M13.01M9.9B
Selling, General & Admin2.63M2.95M3.23M3.16M6.8B
Operating Expenses9.13M10.54M8.83M16.16M16.7M
Depreciation & Amortization00000
EBITDA(9.1M)(10.52M)(8.4M)(15.59M)(13.72M)
EBITDA Margin—————
Operating Income(9.13M)(10.54M)(8.83M)(16.16M)(16.7M)
Operating Margin—————
Interest Income24.02K21.24K429.04K404.02K2.99M
Interest Expense00000
Other Income / Expenses24.02K21.24K429.04K575.3K2.99M
Income Before Tax(9.1M)(10.52M)(8.4M)(15.59M)(13.72M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(9.1M)(10.52M)(8.4M)(15.59M)(13.72M)
Net Margin—————
EPS (Basic)(0.73)(0.83)(0.58)(1.36)(1.85)
EPS (Diluted)(0.73)(0.83)(0.58)(1.36)(1.85)
Weighted Avg Shares12.47M12.72M14.51M11.44M7.41M
Weighted Avg Shares (Diluted)12.47M12.72M14.51M11.48M7.41M

Monopar Therapeutics Inc.

NASDAQ:MNPR

Intrinsic Alpha fair value

Locked

Current Price

$71.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.